Before anyone decides whether your child has ADHD, somebody should decide what else it could be. The evaluation guideline says exactly that — "The PCC should also rule out any alternative cause" — and the list of alternatives that people offer you online is much longer and much less well supported than the list the research actually justifies.

The short answer: one candidate is far better evidenced than any other, and it is not a medical condition at all. Children who are youngest in their school year are diagnosed with ADHD substantially more often than their oldest classmates — in a US cohort of 407,846 children, states with a September 1 cutoff had 85.1 diagnoses per 10,000 among August-born children against 63.6 among September-born, a difference that did not appear in states with different cutoffs or for asthma, diabetes or obesity. After that, the evidence gets thinner fast. Sleep problems, learning disorders and co-occurring anxiety are real and worth assessing. Hearing, vision and giftedness are widely claimed and weakly supported. What follows sorts them by how much evidence there actually is.¹ ² ³

The one with the strongest evidence: how old your child is in the class

This finding has been replicated across countries and health systems, and it is the single most useful thing a parent can bring to an appointment.

The US cohort. Among 407,846 children born 2007–2009 and followed to 2015, in states where the kindergarten cutoff was 1 September: 85.1 diagnoses per 10,000 children born in August against 63.6 per 10,000 born in September — an absolute difference of 21.5 per 10,000. Treatment rates followed the same pattern, 52.9 against 40.4 per 10,000.¹

The controls are what make it convincing: "These differences were not observed for other month-to-month comparisons, nor were they observed in states with non-September cutoff dates for starting kindergarten. In addition, in states with a September 1 cutoff, no significant differences between August-born and September-born children were observed in rates of asthma, diabetes, or obesity."¹

The largest cohort, and the sharper sex finding. Among 937,943 children in British Columbia: boys born in December were 30 percent more likely to be diagnosed than boys born in January, and girls born in December were 70 percent more likely than girls born in January. Prescription rates ran 41 percent and 77 percent higher.⁴

Pooled across 20 papers, the relative-age effect on receiving medication was a risk ratio of 1.27 (95% CI 1.19–1.35) in countries with higher prescribing rates.⁵

And the caveat that keeps this honest. The obvious reading — that these are false diagnoses that later evaporate — is not what the best test found. An individual-participant-data meta-analysis across 41 studies in 15 countries, following 4,708 children for four to thirty-three years: "younger relative age was not statistically significantly associated with ADHD persistence at follow-up (odds ratio 1·02, 95% CI 0·99-1·06; p=0·19)." The authors note that one equally consistent interpretation is that older-in-class children are being under-diagnosed.⁶

So the honest version is: the relative-age effect is real and large, it means immaturity is being read as pathology in some children or maturity is masking it in others, and a clinician should be asked to account for it — not that a young-in-class diagnosis is automatically wrong.

What to ask: "My child is one of the youngest in the class. How has that been accounted for in comparing them with classmates up to a year older?"

Well evidenced: sleep

Insufficient sleep produces ADHD-type behaviour in children who do not have ADHD. In an experiment with 34 typically developing children with no sleep or behaviour problems, and with teachers blinded to the sleep condition, "a cumulative extension of sleep duration of 27.36 minutes was associated with detectable improvement in… emotional lability and restless-impulsive behavior scores of children in school," and "a cumulative restriction of sleep of 54.04 minutes was associated with detectable deterioration on such measures."⁷ Half an hour a night, measurably, in the classroom.

Sleep-disordered breathing is associated with inattention and hyperactivity too: habitual snoring carried an odds ratio of 2.2 for high hyperactivity-inattention scores in a general paediatric sample of 866 children.⁸

But the correction almost nobody carries. When adenotonsillectomy for childhood sleep apnoea was tested in a randomised trial of 464 children, the primary outcome — a measure of attention and executive function — "did not differ significantly according to study group," while behaviour, quality of life and sleep study findings all improved significantly.⁹ So untreated sleep-disordered breathing is worth finding and treating; it is not a reliable explanation for measured attention problems.

What to ask: "How much is my child actually sleeping, and does anyone snore, gasp or stop breathing at night?" And the evaluation guideline lists sleep apnoea among the physical conditions to screen for.¹⁰

Well evidenced, as overlap rather than mimicry: learning disorders

A child who cannot read fluently will look inattentive during reading instruction. That is not a misdiagnosis story; it is a comorbidity story, and the data are good.

In a community sample comparing 225 children with reading disability without ADHD, 139 with both, and 1,502 with neither, "the group with both RD and ADHD was most impaired on most measures," with the overlap attributable at least in part to shared weaknesses in processing speed and working memory. The authors' conclusion: "psychoeducational assessments of RD should always screen for ADHD."¹¹ Twin work indicates "the relation between reading difficulties and inattention symptoms is primarily attributable to common genetic influences."¹²

What to ask: "Has anyone tested reading, writing and maths, or only rated behaviour?"

Well evidenced as co-occurrence, weak as mimicry: anxiety, and adversity

Anxiety. About four in ten children with ADHD also have anxiety, and 77.9 percent of children with ADHD have at least one co-occurring condition.¹³ Cognitive testing does not cleanly separate them: one study of cognitive control and attention in children with ADHD, anxiety and both found "We did not find strong evidence for disorder-specific deficits in attention or cognitive control."¹⁴ What is not established, and is repeated constantly, is that anxiety alone is frequently mislabelled as ADHD. We could not find a primary study quantifying that. The defensible position is that anxiety very often accompanies ADHD, which is exactly why the guideline requires screening for it.¹⁰

Adverse experiences. Children with ADHD have higher rates of every adverse childhood experience measured, with a graded relationship between the number of adversities and the diagnosis — socioeconomic hardship (adjusted odds ratio 1.39), divorce (1.34), familial mental illness (1.55), neighbourhood violence (1.47), incarceration of a household member (1.39) — across a sample representing 58 million children.¹⁵ But these are cross-sectional and parent-reported, and cannot separate "adversity mimics ADHD," "adversity contributes to ADHD," "a child with ADHD increases household strain," and shared family factors. The authors themselves conclude only that "Efforts to improve ADHD assessment and management should consider routinely evaluating for ACEs."¹⁵ The strong claim — that many ADHD diagnoses are really trauma — is not established by this literature. Both should be asked about; neither replaces the other.

Frequently claimed, thinly evidenced: hearing, vision, giftedness

These three appear on every list. They are worth checking for ordinary reasons. They are not well supported as common ADHD mimics, and a page that pretends otherwise is not helping you.

Hearing. In a chart review of 919 children, ADHD rates were higher in children with hearing loss (12.1 percent against 3.6 percent) — but among children without other comorbidities the difference "lost significance after covariate adjustment (p = 0.72)."¹⁶ Get hearing checked because undetected hearing loss impairs school function on its own, not because the evidence shows it is commonly mistaken for ADHD.

Vision. A meta-analysis across 35 studies and 3.25 million participants found ADHD associated with astigmatism (odds ratio 1.79), hyperopia (1.79), strabismus (1.93) and reduced near point of convergence (5.02, 95% CI 1.78–14.11) — but "not with structural alterations of the eye," and the authors explicitly wrote that "Further studies should clarify the causal relationship, if any, between ADHD and problems of vision."¹⁷ Note the width of that convergence interval. Vision therapy marketed as an ADHD treatment is running well ahead of this evidence.

Giftedness or an instructional mismatch. The claim that bright, under-challenged children are misdiagnosed is "well documented" mostly by repetition. The one direct empirical test found rating scales "distinguished well between the gifted group and the other two groups, but not between the gifted/ADHD and ADHD groups" — the opposite of over-identification.¹⁸ And treatment response does not vary by intelligence: in 502 children in a double-blind placebo-controlled crossover, "No significant differences were found with regards to treatment response" across the normal-to-gifted range.¹⁹ A bored child can certainly look inattentive. There is no primary study quantifying how often that produces a diagnosis.

Autism. Worth naming separately, because the framing is dated. Until 2013 the manuals did not permit both diagnoses at once, which is where "autism mimics ADHD" comes from. They co-occur substantially — in a population-derived sample of children with autism, 28.2 percent also met criteria for ADHD²⁰ — and the guideline lists autism among the developmental conditions to screen for.¹⁰

What the evaluation should actually contain

Two guideline standards, worth having in front of you:

Multiple settings. "To make a diagnosis of ADHD, the PCC should determine that DSM-5 criteria have been met, including documentation of symptoms and impairment in more than 1 major setting (ie, social, academic, or occupational), with information obtained primarily from reports from parents or guardians, teachers, other school personnel, and mental health clinicians… The PCC should also rule out any alternative cause."¹⁰

Screening for what else is there. "the PCC should include a process to at least screen for comorbid conditions, including emotional or behavioral conditions (eg, anxiety, depression, oppositional defiant disorder, conduct disorders, substance use), developmental conditions (eg, learning and language disorders, autism spectrum disorders), and physical conditions (eg, tics, sleep apnea)."¹⁰

And the UK guideline adds two things the US one leaves implicit: a diagnosis "should only be made by a specialist psychiatrist, paediatrician or other appropriately qualified healthcare professional with training and expertise in the diagnosis of ADHD," and "A diagnosis of ADHD should not be made solely on the basis of rating scale or observational data. However, rating scales… are valuable adjuncts."²¹

The tests that cannot settle it

Computerised attention tests. They separate groups on average and cannot classify an individual reliably. In a study with a clinical control group — the design that matches the real question — the composite score had "an unacceptable AUC of 0.607 predicting ADHD status," and after controlling for other psychiatric conditions "there were no differences across the ADHD and clinical control groups."²² In 172 children with ADHD, "No significant correlations were observed between" the computerised test and the ADHD rating scale.²³ The high accuracy figures you will see come from studies comparing children with ADHD to healthy controls, which is not the question a clinic faces. The AAP's own line: neuropsychological testing "has not been found to improve diagnostic accuracy in most cases, although it may have benefit in clarifying the child or adolescent's learning strengths and weaknesses."¹⁰

Brainwave tests. One EEG-based device has US marketing authorisation as an aid, and its own authorisation says: it "should only be used by a clinician as confirmatory support for a completed clinical evaluation… The device is NOT to be used as a stand-alone in the evaluation or diagnosis of ADHD."²⁴ Meanwhile the American Academy of Neurology reviewed the same measure and advised against it, citing "the unacceptably high false-positive diagnostic rate," and recommending it "should not be used to confirm an ADHD diagnosis or to support further testing after a clinical evaluation, unless such diagnostic assessments occur in a research setting."²⁵ The underlying marker has since fared badly: a re-analysis across 576 analytic specifications in 1,499 children found "no evidence for robust main effects of diagnosis," concluding that the results "challenge the interpretation of TBR as a reliable standalone biomarker for ADHD."²⁶

If a clinic sells you a brain scan or a computer test as the thing that will answer the question, that is not what those instruments do.

Q&A

Q: What can be mistaken for ADHD in a child? A: The best-evidenced factor is relative age within the school year — the youngest children in a class are diagnosed substantially more often.¹ ⁴ Sleep loss reliably produces ADHD-type behaviour in children without ADHD.⁷ Learning disorders, anxiety and adversity commonly co-occur and should be screened for rather than treated as substitutes.¹⁰

Q: My child is the youngest in their class. Should I be worried the diagnosis is wrong? A: Worth raising explicitly, not worth assuming. The relative-age effect is large and replicated, but the largest follow-up found that younger-in-class children's diagnoses were no more likely to be disconfirmed later — one reading of which is that older-in-class children are being missed.⁶

Q: Could it just be that they don't sleep enough? A: It could be part of it. Half an hour less sleep a night measurably worsened restlessness and emotional lability in children with no sleep or behaviour problems, rated by blinded teachers.⁷ Fixing sleep is worth doing regardless of the diagnostic answer.

Q: Should I get their hearing and eyes checked first? A: Yes — for ordinary reasons. The evidence that either is a common ADHD mimic is thin, and the one hearing study that adjusted for comorbidities lost its effect.¹⁶ ¹⁷ Cheap, quick, and worth ruling out.

Q: Is there a test that proves it? A: No. The guideline says neuropsychological testing "has not been found to improve diagnostic accuracy in most cases," and the one EEG device with marketing authorisation is explicitly "NOT to be used as a stand-alone in the evaluation or diagnosis of ADHD."¹⁰ ²⁴

Q: My child behaves fine at home. Doesn't that rule it out? A: It is a reason to look closely, not a rule-out. The criteria require impairment in more than one setting, and settings differ enormously in structure and demand.¹⁰ It is also the pattern most often reported for girls. Do girls get missed? →

Ready to find someone who evaluates children properly? Filter by approach, schedule and payment route → · ADHD in children: the parent map → · The printable evaluation prep →

In crisis? Call or text 988 — free, 24/7.

Sources

  1. Layton TJ, Barnett ML, Hicks TR, Jena AB, "Attention deficit-hyperactivity disorder and month of school enrollment," New England Journal of Medicine 379(22), 2018, 2122–2130 — 407,846 children; 85.1 against 63.6 diagnoses per 10,000 for August- versus September-born children in states with a September 1 cutoff, and the negative controls — doi.org.
  2. Wolraich ML, Hagan JF Jr, Allan C, et al., "Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents," Pediatrics 144(4), 2019, e20192528 — key action statement 2, "The PCC should also rule out any alternative cause" — pmc.ncbi.nlm.nih.gov.
  3. Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA, "ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis," International Journal of Epidemiology 43(2), 2014, 434–442 — pmc.ncbi.nlm.nih.gov.
  4. Morrow RL, Garland EJ, Wright JM, Maclure M, Taylor S, Dormuth CR, "Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children," Canadian Medical Association Journal 184(7), 2012, 755–762 — 937,943 children; boys born in December 30% more likely and girls 70% more likely to be diagnosed than those born in January — pmc.ncbi.nlm.nih.gov.
  5. Holland J, Sayal K, "Relative age and ADHD symptoms, diagnosis and medication: a systematic review," European Child and Adolescent Psychiatry 28(11), 2019, 1417–1429 — "a modest relative age effect in countries with higher prescribing rates, risk ratio = 1.27 (95% CI 1.19-1.35) for receipt of medication" — pmc.ncbi.nlm.nih.gov.
  6. SIMBA study group, "Association between relative age at school and persistence of ADHD in prospective studies: an individual participant data meta-analysis," The Lancet Psychiatry 10(12), 2023, 922–933 — 41 studies, 15 countries, 4,708 children; "younger relative age was not statistically significantly associated with ADHD persistence at follow-up (odds ratio 1·02, 95% CI 0·99-1·06; p=0·19)" — doi.org.
  7. Gruber R, Cassoff J, Frenette S, Wiebe S, Carrier J, "Impact of sleep extension and restriction on children's emotional lability and impulsivity," Pediatrics 130(5), 2012, e1155–e1161 — 34 typically developing children, teachers blinded to condition; the 27.36-minute extension and 54.04-minute restriction findings — doi.org.
  8. Chervin RD, Archbold KH, Dillon JE, et al., "Inattention, hyperactivity, and symptoms of sleep-disordered breathing," Pediatrics 109(3), 2002, 449–456 — 866 children; habitual snoring odds ratio 2.2 (95% CI 1.4–3.6) — doi.org.
  9. Marcus CL, Moore RH, Rosen CL, et al., "A randomized trial of adenotonsillectomy for childhood sleep apnea," New England Journal of Medicine 368(25), 2013, 2366–2376 — 464 children; "the change from baseline to follow-up did not differ significantly according to study group" on the attention and executive function measure, with significant improvements in behavioural, quality-of-life and polysomnographic findings — pmc.ncbi.nlm.nih.gov.
  10. Wolraich ML, Hagan JF Jr, Allan C, et al., 2019, as above — key action statements 2 and 3 quoted in full, and the statement that neuropsychological testing "has not been found to improve diagnostic accuracy in most cases."
  11. Willcutt EG, Petrill SA, "Comorbidity between reading disability and ADHD in a community sample," Mind, Brain, and Education 17(4), 2023, 338–348 — "psychoeducational assessments of RD should always screen for ADHD" — pmc.ncbi.nlm.nih.gov.
  12. Willcutt EG, Pennington BF, Olson RK, DeFries JC, "Understanding comorbidity: a twin study of reading disability and attention-deficit/hyperactivity disorder," American Journal of Medical Genetics Part B 144B(6), 2007, 709–714 — "the relation between reading difficulties and inattention symptoms is primarily attributable to common genetic influences" — doi.org.
  13. Danielson ML, Claussen AH, Bitsko RH, et al., "ADHD prevalence among U.S. children and adolescents in 2022," Journal of Clinical Child and Adolescent Psychology 53(3), 2024, 343–360 — "77.9% had at least one co-occurring disorder" — doi.org; Centers for Disease Control and Prevention, ADHD data and statistics — cdc.gov.
  14. Boen R, et al., "Attention and cognitive control in children with ADHD and comorbid anxiety disorder," Journal of Attention Disorders 30(8), 2026, 1036–1052 — "We did not find strong evidence for disorder-specific deficits in attention or cognitive control" — doi.org.
  15. Brown NM, Brown SN, Briggs RD, Germán M, Belamarich PF, Oyeku SO, "Associations between adverse childhood experiences and ADHD diagnosis and severity," Academic Pediatrics 17(4), 2017, 349–355 — 76,227 children representing 58,029,495; the adjusted odds ratios and the graded relationship; "Efforts to improve ADHD assessment and management should consider routinely evaluating for ACEs" — doi.org.
  16. Ramanathan D, Kipnis P, Klaas P, Aaron KA, Anne S, "Attention-deficit/hyperactivity disorder in children with hearing loss," International Journal of Pediatric Otorhinolaryngology 171, 2023, 111612 — 919 children; "there was loss of significance after covariate adjustment (p = 0.72)" — doi.org.
  17. Bellato A, Perna J, Ganapathy PS, et al., "Association between ADHD and vision problems: a systematic review and meta-analysis," Molecular Psychiatry 28(1), 2023, 410–422 — 35 studies in the meta-analyses, 3,250,905 participants; the odds ratios quoted; "Further studies should clarify the causal relationship, if any, between ADHD and problems of vision" — pmc.ncbi.nlm.nih.gov.
  18. François-Sévigny J, Pilon M, Gauthier LA, "Differences in parents and teachers' perceptions of behavior manifested by gifted children with ADHD," Brain Sciences 12(11), 2022, 1571 — rating scales "distinguished well between the gifted group and the other two groups, but not between the gifted/ADHD and ADHD groups" — pmc.ncbi.nlm.nih.gov.
  19. Grizenko N, Qi Zhang DD, Polotskaia A, Joober R, "Efficacy of methylphenidate in ADHD children across the normal and the gifted intellectual spectrum," Journal of the Canadian Academy of Child and Adolescent Psychiatry 21(4), 2012, 282–288 — 502 children; "No significant differences were found with regards to treatment response" — pmc.ncbi.nlm.nih.gov.
  20. Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G, "Psychiatric disorders in children with autism spectrum disorders," Journal of the American Academy of Child and Adolescent Psychiatry 47(8), 2008, 921–929 — "attention-deficit/hyperactivity disorder (28.2%, 95% CI 13.3-43.0)" — doi.org.
  21. National Institute for Health and Care Excellence, "Attention deficit hyperactivity disorder: diagnosis and management," NICE guideline NG87, recommendations 1.3.1 to 1.3.3 — nice.org.uk.
  22. Shura RD, Stern MJ, Varela JL, Fannick EH, Canu WH, "Diagnostic utility of a continuous performance test," Archives of Clinical Neuropsychology 41, 2026, acag036 — "an unacceptable AUC of 0.607 predicting ADHD status"; "After controlling for psychiatric comorbidity, there were no differences across the ADHD and clinical control groups" — doi.org.
  23. Poh XWW, Lim SSY, Chew YY, Lim-Ashworth NSJ, Lim CG, "Continuous performance test and clinical measures in children with ADHD," Singapore Medical Journal 65(10), 2024, 558–563 — 172 children aged 6–12; "No significant correlations were observed between CCPT-II and ADHD-RS" — doi.org.
  24. US Food and Drug Administration, de novo decision summary for the Neuropsychiatric EEG-Based ADHD Assessment Aid (NEBA), granted 15 July 2013 — "should only be used by a clinician as confirmatory support for a completed clinical evaluation or as support for the clinician's decision to pursue further testing following a clinical evaluation. The device is NOT to be used as a stand-alone in the evaluation or diagnosis of ADHD" — accessdata.fda.gov.
  25. Gloss D, Varma JK, Pringsheim T, Nuwer MR, "Practice advisory: the utility of EEG theta/beta power ratio in ADHD diagnosis," Neurology 87(22), 2016, 2375–2379 — "There is a risk for significant harm to patients from ADHD misdiagnosis because of the unacceptably high false-positive diagnostic rate of EEG theta/beta power ratio and frontal beta power" — pmc.ncbi.nlm.nih.gov.
  26. Strzelczyk D, Vetsch A, Langer N, "A multiverse analysis of the theta/beta ratio in ADHD," eLife 15, 2026, RP111114 — 1,499 participants with a validation sample of 381 and 576 analytic specifications; "no evidence for robust main effects of diagnosis… Our results challenge the interpretation of TBR as a reliable standalone biomarker for ADHD" — doi.org.

Paid for by participating therapists. Inclusion is computed from availability data — never purchased. No ads, no data sold.